Verily-led consortium secures $9.2M NIH award extension for platform to advance systems biology research

Dallas, TX – December 18, 2025 – A data and technology consortium led by Verily, in collaboration with the Broad Institute of MIT and Harvard, DataTecnica, Northwestern University Feinberg School of Medicine, Sage Bionetworks, Technome, and Vanderbilt University Medical Center has secured a two-year renewal for the National Institutes of Health (NIH) System Biology (SysBio) award, totaling $9.2 million. This continued funding builds on the initial award announced in 2024.

The additional funding will further the development and implementation of the FAIRplex platform, designed to empower researchers to efficiently find, access, and analyze data from Accelerating Medicines Partnership® (AMP®) projects, fostering a deeper understanding of the systems biology underpinning health and disease. The focus for this next phase shifts from foundational development to operational readiness and deeper integration with key AMP® projects.

AMP®, a public private partnership from NIH, the Foundation for NIH (FNIH), the U.S. Food and Drug Administration (FDA), industry, and advocacy organizations, covers a vast range of diseases, including Alzheimer’s disease, autoimmune and immune-mediated diseases, gene therapies, common metabolic disorders, heart failure, Parkinson's disease, and schizophrenia. The multimodal datasets within the platform include phenotypic, clinical, molecular, and patient-reported outcomes data.

This renewal signifies the NIH’s continued commitment to the collaborative FAIRplex initiative, recognizing the significant progress made by the consortium organizations in Year 1. The partners will continue to build and refine a production system that offers:

• Tools for harmonizing health data at scale.
• An open access portal for summary representations and data visualization.
• A search interface for discovering study data and building federated cohorts.
• A researcher workbench with interactive analytical tools and batch workflow capabilities.
• A federation integration kit compatible with NIH and GA4GH standards for authentication and authorization.

The partners will also advance security and governance protocols, while continuing to conduct user testing and outreach to ensure impact for the broader scientific community. While initially built for AMP® projects, the work can be adapted for use across other datasets from NIH and external partners, providing the same benefits of curation, governance, and access, and leading to broader data access for greater research impact.

"We are proud to continue our partnership with the NIH and our consortium partners on the FAIRplex platform," said Andrew Trister, MD, PhD, Chief Medical and Scientific Officer at Verily. "This renewed funding underscores the critical importance of creating a unified, accessible, and secure data ecosystem as researchers look to apply advanced AI and machine learning techniques to accelerate scientific findings. By providing seamless analysis across AMP® projects, FAIRplex will serve as a critical enabler to ultimately bring new insights and therapies to patients faster."

The continued development of the FAIRplex platform, grounded in collaborative innovation, is critical for overcoming the challenges of disparate data governance, types, and platforms across various AMP® projects. By creating a unified and accessible platform, FAIRplex ultimately aims to power scientific discoveries that will be translated into new medicines and improved health outcomes for patients.

About Verily
Verily is an Alphabet data platform and AI company purpose-built for precision health. We combine deep clinical, regulatory, and technological expertise to provide our customers with patient-centric solutions that make healthcare more personal and precise. Verily solutions are designed to make healthcare data AI-ready and fit for purpose across care, research, and public health. For more information about Verily please visit: verily.com.

About the Broad Institute
Broad Institute is an independent, non-profit research organization whose mission is to understand the roots of disease and close the gap between new biological insights and impact for patients. Founded in 2004 by the visionary Los Angeles philanthropists Eli and Edythe Broad, the Broad Institute exists at the intersection of scientific disciplines, convening scientists and other experts from genomics, cell biology, chemistry, engineering, neuroscience, therapeutics, artificial intelligence/machine learning, computational biology, and public health. The Broad Institute engages thousands of scientists from MIT, Harvard, Harvard’s primary teaching hospitals, other academic institutions, and leading corporate partners in the pharmaceutical and biotechnology industries, all of whom share the goal of translating research findings into safe and effective therapeutic interventions for all common and rare diseases.

About DataTecnica
From data science (machine learning, statistics, bioinformatics, and epidemiology) to computer science (AI/LLMs, distributed systems, high-performance computing, and human-computer interaction) to biology (genetics and multi-omics) and medicine (imaging, neurology and public health). We build software tools and platforms optimized for our clients, accelerating their research across federal health, biotech and philanthropy. We are a diverse team with integrative expertise from all the essential areas of data science and technology to advance healthcare.

About Northwestern University Feinberg School of Medicine
Northwestern University Feinberg School of Medicine, founded in 1859, attracts talented individuals to its faculty, staff, and student body through its cutting-edge research initiatives, superb clinical affiliates, global outlook, and innovative curriculum. Located in the heart of Chicago’s Magnificent Mile, Feinberg has built a national reputation for excellence through a strong history of collaborative, interdisciplinary medical education and research, and along with Northwestern Memorial Hospital and Northwestern Medical Group is part of the premier academic health system known as Northwestern Medicine. Feinberg stands out among the nation's research-intensive medical schools and consistently receives high marks in U.S. News & World Report surveys. Through its affiliates, it provides patient care to thousands of individuals every year, and plays an integral part in the communities it serves.

About Sage Bionetworks
Sage Bionetworks is a non-profit health research organization based in Seattle, Washington. Our mission is to drive a new age of scientific discovery through truly open science and radical collaboration. We guide responsible data sharing and reuse, benchmark scientific methods and results, and empower participants to be active partners in research. To learn more, visit sagebionetworks.org

About Technome
Technome is a technology and life sciences company that specializes in simplifying and managing the complexities of bioinformatics data sharing. We focus on transforming intricate back-end bioinformatics processes into more accessible and user-friendly front-end systems. Our services make large-scale data manageable for collaborative research programs. Technome's mission is to make bioinformatics data more accessible and manageable, thereby enhancing the ability of research teams to collaborate and innovate effectively.

About Vanderbilt University Medical Center
Vanderbilt University Medical Center (VUMC) is the largest comprehensive research, teaching and patient care health system in the Mid-South region. Based in Nashville, Tennessee, VUMC sees more than 3.5 million patient visits per year in its seven hospitals and 180+ ambulatory locations. The Medical Center is the largest non-governmental employer of Middle Tennesseans, with more than 43,000 staff, including 4,930 employed clinicians. An epicenter for biomedical research, VUMC is the recipient of more than $1 billion in annual research awards from government, industry, foundations and donors. For more information and the latest news follow VUMC on Facebook, LinkedIn, Twitter and at VUMC News.